Feasibility Study of a Novel Transapical Chordal Implantation System in a Porcine Model

Transapical beating -heart mitral repair with chordal implantation system has been considered as an alternative treatment for degenerative mitral regurgitation. This study aimed to assess the feasibility and safety of the E -Chord system (Med-Zenith Medical, Beijing, China) for transapical beating -heart mitral valve repair in a porcine model. Artificial chordae were transapically implanted on the mitral valves of 12 anesthetized pigs under epicardial echocardiographic guidance and secured outside the left ventricular apex. The study endpoints included procedural success, device durability, and tissue response to the device. The procedural success rate was 100% (12/12). All animals were implanted with E -Chord in the anterior and posterior leaflets, respectively, and survived uneventfully until euthanized as planned. During the 180 -day follow-up, no animal had significant mitral valve dysfunction. The gross observation showed no evidence of anchor detachment and chordal rupture, and there was no obvious damage or changes to mitral leaflets. Microscopic evaluation revealed that the endothelialization of anchor and chordae was completed 90 days after implantation and there was no evidence of chordal rupture, thrombosis, or infection during the 180 -day follow-up. The E -Chord system was found to be feasible and safe for heart -beating mitral chordal implantation in a porcine model. The findings of this study suggest that the E -Chord system may be a potential alternative for the treatment of degenerative mitral regurgitation in humans.